BriaCell presents positive clinical data in three posters at the San Antonio Breast Cancer Symposium (SABCS ... biotechnology company that ...
News
- BriaCell Presents Outstanding Phase 2 Survival & Promising Phase 3 Clinical Data at SABCS® 2025
- January 16, 2026 Deadline Approaching: Join Class Action Against Skye Bioscience, Inc ...
... San Antonio Spurs Game Schedule · KGBT 4.1 2025 – 26 Dallas Mavericks ... January 16, 2026 Deadline Approaching: Join Class Action Against Skye ...
- NiKang Therapeutics Presents Discovery of NKT5097, a First-in-Class, Highly Potent and ...
(“NiKang”), a clinical stage biotech company focused on developing ... San Antonio Breast Cancer Symposium (SABCS 2025) being held December 9 ...
- Intensity Therapeutics, Inc. to Present Two Posters at the 2025 San Antonio Breast Cancer ...
(Nasdaq: INTS) ("Intensity" or "the Company"), a late-stage clinical biotechnology ... San Antonio Breast Cancer Symposium ("SABCS"), in San Antonio, TX ...
- UT San Antonio advances detection, prevention of hidden stomach infections linked to cancer
Research scientists and clinicians at UT Health San Antonio are working to halt one of the most persistent bacterial infections that silently affects ...